Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.94 -0.68%   SPY: 132.83 -0.38%
Profile Portfolio  


  Track this Pro and follow their portfolio moves with tickerspy™ alerts  

VHCP Management

  Performance       Similar Pro Portfolios       Community  
 
Today:
Week:
1-month:
All-time:
+0.2%
+3.7%
+9.0%
-7.6%
vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500:
+0.6%
+6.1%
+13.5%
-13.2%
 

Data since: Jan-1-2011
Current Portfolio: Q4 2011


     
Hal Mintz +2.8%
BAM Capital +0.8%
Jeffrey R. Jay -1.5%
     
1 member Tracking
Share this Pro on Facebook
Share this Pro on Twitter
 
                     
     
 
Chart View
1 week
 
1 month
 
3 months
 
6 months
   
 
 

 
 
 
 
   
     
 
Portfolio Detail
 
  Standard View     Performance View    
Click a column to sort | Scroll over columns for more information
 
 Ticker Last Trade Today's Change Volume  % of
Daily
Mkt Cap  Div Yield  % off
52wk lw
% from
52wk hg
Q4 2011 View as: Alerts Holdings Detail
 ACAD $1.56 -0.02 -1.27% 282,108 76% $82.5M - 73% -32% +44.4% $3.6M | 3.4M shares - No Change
 ANAC $5.40 +0.09 +1.69% 19,298 59% $170.1M - 46% -28% -12.9% $12.4M | 2.0M shares - No Change
 ANTH $2.01 -0.09 -4.29% 463,921 87% $82.5M - 40% -78% -67.3% $4.1M | 675.0K shares - No Change
 CHTP $2.12 -0.06 -2.75% 532,847 61% $142.1M - 11% -65% -58.7% $20.0M | 3.9M shares - No Change
 DEPO $5.46 -0.09 -1.62% 348,112 85% $303.7M - 30% -41% +5.4% $7.6M | 1.5M shares - No Change
 DRRX $0.79 -0.03 -3.71% 293,784 123% $69.1M - 16% -78% -33.1% $5.2M | 4.4M shares - No Change
 GTXI $3.27 -0.09 -2.68% 181,836 49% $205.3M - 40% -52% -2.7% $7.1M | 2.1M shares - No Change
 IRWD $12.50 -0.14 -1.11% 211,123 68% $1.3B - 25% -24% +4.4% $28.7M | 2.4M shares - No Change
 MDVN $88.70 +2.58 +3.00% 753,010 113% $3.2B - 519% 0% +92.4% $30.0M | 650.2K shares - No Change
 NBIX $6.85 -0.04 -0.58% 320,893 73% $454.1M - 26% -31% -19.4% $25.0M | 2.9M shares - No Change
 NPSP $7.32 -0.15 -2.01% 677,745 141% $630.6M - 68% -29% +11.1% $12.8M | 1.9M shares - No Change
 RDEA $31.75 +0.01 +0.03% 402,685 23% $1.1B - 141% -0% +88.9% $9.2M | 545.4K shares - No Change
 YMI $2.07 +0.02 +0.98% 3,102,239 416% $241.5M - 101% -45% +26.2% $663.0K | 404.3K shares - New Holding
 ZGNX $1.82 -0.07 -3.70% 147,008 90% $118.9M - 39% -64% -18.0% $5.5M | 2.5M shares - No Change
Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Discuss VHCP Management's portfolio
 
Latest Portfolio Notes & Links
 
View: Headlines   |   Message Board   |   Portfolio Notes  
 
 
Zogenix Reports First Quarter 2012 Financial Results
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 14, 04:00PM from (www.globenewswire.com)

SAN DIEGO, May 14, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing  more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
NASDAQ Changes Up Biotech Index Members & Weightings
CLDX  CBRX  CERS  BPAX  CRME  RPTP  DRRX  INFI  IBB  FOLD  JAZZ  OMER  CBPO  OREX  TSRX  PCRX  BBH  XBI  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 14, 07:59AM from (247wallst.com)
Index changes are generally speaking a fairly routine event. They can also create underlying moves in the companies added  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pomerantz Law Firm Reminds Shareholders of Chelsea Therapeutics International Ltd. of Upcoming Deadline -- CHTP
CHTP  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 11, 01:02PM from (www.globenewswire.com)
NEW YORK, May 11, 2012 (GLOBE NEWSWIRE) -- Shareholders of Chelsea Therapeutics International Ltd. ("Chelsea" or  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
GlaxoSmithKline to Get Hostile with Offer for Human Genome
HGSI  AZN  RDEA  ILMN  GSK  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 09, 09:15AM from (www.benzinga.com)
It was revealed on Wednesday that GlaxoSmithKline (NYSE: GSK) is looking to make a hostile takeover move for Human Genome  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Medivation Reports First Quarter Financial Results and Provides Corporate Update
MDVN  
Linked by marketwire ( track newsfeed | ignore newsfeed ) - May 08, 04:10PM from (www2.marketwire.com)
Medivation, Inc. (NASDAQ: MDVN) today provided a corporate update and reported its financial results for the first quarter  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Depomed Reports First Quarter Financial Results
DEPO  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 08, 04:05PM

MENLO PARK, Calif., May 8, 2012 /PRNewswire/ -- Depomed,  more ...
Flag Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Four U.S. Patents Issued for REMOXY
PTIE  DRRX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 03, 08:30AM from (www.globenewswire.com)
AUSTIN, Texas, May 3, 2012 (GLOBE NEWSWIRE) -- Pain Therapeutics Inc. (Nasdaq:PTIE) a biopharmaceutical company, today announced  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Zogenix Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 03, 07:30AM from (www.globenewswire.com)
SAN DIEGO, May 3, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Neurocrine Biosciences Reports First Quarter 2012 Results
NBIX  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 02, 04:05PM

SAN DIEGO, May 2, 2012 /PRNewswire/ -- Neurocrine Biosciences,  more ...
Flag Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
CORRECTING and REPLACING -- Chelsea Therapeutics Reports First Quarter 2012 Results
CHTP  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 01, 04:46PM from (www.globenewswire.com)

CHARLOTTE, N.C., May 1, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported  more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Chelsea Therapeutics Reports First Quarter 2012 Results
CHTP  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 01, 04:15PM from (www.globenewswire.com)

CHARLOTTE, N.C., May 1, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported  more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Depomed to Release First Quarter Financials on May 8 and to Present at 11th Annual JMP Research Conference on May 14
DEPO  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 01, 06:00AM from (www.globenewswire.com)
MENLO PARK, Calif., May 1, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that it will release its  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pomerantz Law Firm Reminds Shareholders of Chelsea Therapeutics International Ltd. of Upcoming Deadline -- CHTP
CHTP  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - April 27, 11:57AM from (www.globenewswire.com)
NEW YORK, April 27, 2012 (GLOBE NEWSWIRE) -- Shareholders of Chelsea Therapeutics International Ltd. ("Chelsea"  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Results From Chelsea Therapeutics' Pivotal Northera(TM) (Droxidopa) Study to be Presented at the American Academy of Neurology's Annual Meeting
CHTP  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - April 27, 08:00AM from (www.globenewswire.com)
CHARLOTTE, N.C., April 27, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Chelsea Therapeutics is a Proud Sponsor of the Parkinson's Unity Walk
CHTP  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - April 25, 08:00AM from (www.globenewswire.com)
CHARLOTTE, N.C., April 25, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced today  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
PREMIUM PARTNER CONTENT
Featured Biotech Investment Idea Ardea Surges on Buyout
AZN  RDEA  
Posted by bullmarket ( track member | ignore member ) - April 23, 04:21PM
In mid-March, we featured a developmental biotech stock we liked called Ardea Biosciences that was developing a drug  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
What’s A Better Buyout: Ardea or Amylin?
BMY  MRK  AMLN  AZN  RDEA  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - April 23, 02:54PM from (247wallst.com)
Ardea Biosciences, Inc. (NASDAQ: RDEA) is soaring today on news that AstraZeneca PLC (NYSE: AZN) is paying about $1.26 billion  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 36



Close [X]  
Post a description about this portfolio.
(150 character limit)

Click to close X

Use portfolios to track tickers you're interested in. News related to your tickers will appear below the portfolio. Tickers in your portfolios will generate Alerts on your tickerspy Alerts page.

The Recent Tickers portfolio saves the tickers you've recently viewed on the site.

Click to close X

By matching similar portfolios, tickerspy helps members find institutional and individual investors with strategies similar to their own.

Click to close X

Portfolio performance for tickerspy member portfolios is calculated by equally weighting all of the stocks held in the portfolio.

Click to close X

Performance View offers a snapshot of how individual portfolio positions have performed since being added (or shorted) as well as a look at the individual stocks' performance over various time periods. In the case of "shorts," a decline in price will result in a positive gain.

Portfolio History offers a view of all current and past holdings in a portfolio.

Click to close X

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.

Click to close X

To calculate "all-time" Pro performance, we combine all of the quarterly holdings reports for that Pro investor. The initial date used is the start date of the first quarterly holdings report we have in our database. Start dates vary based on the first quarterly holdings report we have for each Pro. Please see our Institutional Holdings Disclaimer (located at the bottom of this page) for more on how we calculate Pro portfolio performance estimates. tickerspy is not affiliated with any of Pro investors profiled on our web site.

Click to close X

Your primary portfolio will appear in other member’s Tracking Hubs when they track your performance. Your primary portfolio is also used in our Ideas & Research section, where your portfolio is compared with the portfolios of other members, and elsewhere on the site where other portfolio comparisons are made.

Note: Primary portfolios must contain at least five stocks of greater than $1 per share. If you have elected to make your primary portfolio private or if your portfolio is not eligible to be primary, it will not appear in the Ideas & Research section or on the front page.

Click to close X

Primary portfolio

Click to close X
Click the Alerts links in your portfolio to see news from the last 36 hours as well as data alerts displaying unusual price and volume action. You will also see Alerts related to the activity of other tickerspy members. To see more Alerts, visit your customized Alerts page. And for more Alerts info, visit our Alerts FAQ.
Click to close X
The Recent Tickers portfolio saves the tickers you've recently viewed on the site.